How the World’s First Biolabs Client Portal GALEXI™ Delivers Real-Time Study Management for Biotechs
In this webinar, you will find out first-hand how the Agilex Biolabs Client Portal GALEXI™ delivers real-time study management for biotechs.
Australia-based Agilex Biolabs, the APAC region’s most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, will detail the benefits of GALEXI™ which has been launched in response to the continued global COVID-19 outbreak and increased client demand for the Australian biolab.
GALEXI™ is the first of its type globally for a major bioanalytics company. GALEXI™ is particularly valuable for international clients working across different time zones requiring instant access to real-time study management. The highly-secure portal has recently completed live testing with a number of US clients and is being rolled out this month and offered to all clients.
Agilex Biolabs CEO Jason Valentine said:
“This is just another way we are adapting to the international COVID-19 environment to support our clients. Australian clinical trials have remained open for business and Agilex Biolabs is a designated essential service so clients can be assured of study continuity.
Australia has led the world in keeping COVID-19 numbers down to almost zero across the country by acting swiftly to minor outbreaks. We have extensive COVID protocols in place to respond immediately to circuit breakers, ensuring safety for our team and business as usual for our clients.”
Agilex Biolabs, which has a 24-year track record, is known internationally for its continued investment in the latest technology, and for attracting some of the leading scientists from Australia and around the world.
